Tom Jefferson
#83,988
Most Influential Person Now
Researcher
Tom Jefferson 's AcademicInfluence.com Rankings
Tom Jefferson biology Degrees
Biology
#8405
World Rank
#11474
Historical Rank
Genetics
#1049
World Rank
#1147
Historical Rank
Molecular Biology
#1426
World Rank
#1453
Historical Rank
Biochemistry
#1561
World Rank
#1692
Historical Rank
Download Badge
Biology
Tom Jefferson 's Degrees
- Bachelors Biology University of Oxford
Similar Degrees You Can Earn
Why Is Tom Jefferson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Tom Jefferson is a British epidemiologist, based in Rome, Italy, who works for the Cochrane Collaboration. Jefferson is an author and editor of the Cochrane Collaboration's acute respiratory infections group, as well as part of four other Cochrane groups. He was also an advisor to the Italian National Agency for Regional Health Services.
Tom Jefferson 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996) (1857)
- Physical interventions to interrupt or reduce the spread of respiratory viruses. (2010) (704)
- Increasing value and reducing waste: addressing inaccessible research (2014) (667)
- Vaccines for preventing influenza in the elderly. (2010) (631)
- Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review (2005) (617)
- Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review (2008) (523)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. (2012) (488)
- Vaccines for preventing influenza in healthy children. (2012) (435)
- Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments (2014) (387)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis (2009) (332)
- Vaccines for preventing influenza in healthy adults. (2014) (311)
- Vaccines for measles, mumps and rubella in children. (2013) (311)
- Effects of editorial peer review: a systematic review. (2002) (303)
- Antivirals for influenza in healthy adults: systematic review (2006) (294)
- Editorial peer review for improving the quality of reports of biomedical studies. (2007) (290)
- Peer Review in Health Sciences (1999) (256)
- Prevention and early treatment of influenza in healthy adults. (2000) (233)
- Vaccines for preventing influenza in healthy adults. (2000) (226)
- Measuring the quality of editorial peer review. (2002) (216)
- Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review (2005) (211)
- Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom (2000) (196)
- Vaccines for preventing influenza in people with asthma. (2000) (193)
- Restoring invisible and abandoned trials: a call for people to publish the findings (2013) (180)
- The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience (2012) (170)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. (2014) (170)
- Viral cultures for COVID-19 infectious potential assessment – a systematic review (2020) (159)
- The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). (2002) (151)
- Vaccines for preventing influenza in healthy adults. (2014) (147)
- Influenza vaccination for healthcare workers who work with the elderly. (2006) (140)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults. (2011) (139)
- Vaccines for preventing influenza in healthy children. (2008) (134)
- Elementary Economic Evaluation in Health Care (1998) (134)
- Quality of systematic reviews of economic evaluations in health care. (2002) (124)
- Amantadine and rimantadine for influenza A in adults. (2006) (121)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children (2010) (121)
- Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. (2006) (120)
- Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. (2002) (109)
- Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. (2004) (109)
- Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments (2014) (106)
- Systematic review of the effects of pertussis vaccines in children. (2003) (97)
- Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review (2007) (95)
- Vaccines for preventing influenza in the elderly. (2010) (94)
- Influenza vaccination: policy versus evidence (2006) (93)
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. (2013) (93)
- Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 - Face masks, eye protection and person distancing: systematic review and meta-analysis (2020) (90)
- Amantadine and rimantadine for preventing and treating influenza A in adults. (2004) (85)
- Unintended events following immunization with MMR: a systematic review. (2003) (85)
- Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. (2006) (84)
- The development of standardized case definitions and guidelines for adverse events following immunization. (2007) (83)
- Viral cultures for COVID-19 infectivity assessment. Systematic review (2020) (81)
- Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. (2016) (81)
- Interventions for the interruption or reduction of the spread of respiratory viruses. (2007) (79)
- Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports (2013) (76)
- Vaccines for preventing tick-borne encephalitis. (2009) (74)
- Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet. (1998) (73)
- Vaccines for preventing influenza in healthy adults. (2010) (68)
- Rethinking credible evidence synthesis (2012) (64)
- Is vaccination against hepatitis B efficient? A review of world literature. (1994) (61)
- An exercise on the feasibility of carrying out secondary economic analyses. (1996) (60)
- Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review (2009) (60)
- Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process (2017) (58)
- Vaccines for preventing influenza in people with asthma. (2004) (57)
- A review of the effectiveness and cost-effectiveness of interventions delivered in primary and secondary schools to prevent and/or reduce alcohol use by young people under 18 years old (2007) (56)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults. (2006) (55)
- Multisystem failure: the story of anti-influenza drugs (2014) (54)
- The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias (2018) (53)
- Redundant publication in biomedical sciences: Scientific misconduct or necessity? (1998) (53)
- Balancing benefits and harms in health care: (2003) (52)
- “Adaptive pathways” to drug authorisation: adapting to industry? (2016) (51)
- Vaccination and its adverse effects: real or perceived (1998) (49)
- Influenza vaccination for healthcare workers who work with the elderly. (2010) (48)
- Ensuring safe and effective drugs: who can do what it takes? (2011) (47)
- Quality of economic evaluations in health care (2002) (46)
- Influenza vaccination for healthcare workers who work with the elderly: systematic review. (2010) (46)
- The effectiveness and safety of vaccines against human anthrax: a systematic review. (1998) (45)
- Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. (2009) (43)
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. (2016) (42)
- Standardized case definitions of adverse events following immunization (AEFI). (2004) (40)
- SARS-CoV-2 and the role of airborne transmission: a systematic review (2021) (40)
- Shortcomings of peer review in biomedical journals (2001) (39)
- Possible harms of oseltamivir—a call for urgent action (2009) (37)
- No evidence that vaccines cause insulin dependent diabetes mellitus. (1998) (37)
- Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. (2009) (37)
- Vaccines for preventing influenza in healthy children. (2006) (36)
- How To Survive Peer Review (2002) (36)
- SARS-CoV-2 and the role of fomite transmission: a systematic review. (2021) (34)
- Real or perceived adverse effects of vaccines and the media—a tale of our times (2000) (33)
- Antivirals for the common cold (2009) (32)
- SARS-CoV-2 viral load and the severity of COVID-19 (2020) (32)
- Are guidelines for peer-reviewing economic evaluations necessary? A survey of current editorial practice. (1995) (32)
- Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). (2010) (31)
- Should British soldiers be vaccinated against hepatitis A? An economic analysis. (1994) (30)
- Transparency of COVID-19 vaccine trials: decisions without data (2021) (29)
- SARS-CoV-2 and the role of orofecal transmission: a systematic review (2020) (29)
- Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review (2003) (28)
- The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer. (2013) (28)
- Inactivated influenza vaccines: methods, policies, and politics. (2009) (28)
- Amantadine and rimantadine for preventing and treating influenza A in adults. (2004) (27)
- Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports (2014) (26)
- The Brighton Collaboration-enhancing vaccine safety. (2004) (26)
- Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency (2016) (25)
- Vaccines for preventing influenza in people with asthma (Cochrane Review). (2000) (24)
- Demyelinating Disease and Hepatitis B Vaccination (2001) (24)
- Vaccines for preventing anthrax. (1998) (23)
- Vaccines for preventing plague. (1998) (23)
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review (2018) (23)
- Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011 (2017) (23)
- Safety of influenza vaccines in children (2005) (22)
- The quest for trials on the efficacy of human vaccines. Results of the handsearch of Vaccine. (1996) (22)
- Implementing a guideline for the treatment of type 2 diabetics: results of a Cluster- Randomized Controlled Trial (C-RCT) (2007) (21)
- Methodological issues arising from systematic reviews of the evidence of safety of vaccines. (2004) (21)
- The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors (2018) (21)
- Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review (2021) (20)
- Polysaccharide pneumococcal vaccines (2002) (20)
- Inactivated influenza vaccines in the elderly—are you sure? (2007) (20)
- When to include clinical study reports and regulatory documents in systematic reviews (2018) (20)
- Angelo Celli and research on the prevention of malaria in Italy a century ago (2012) (19)
- Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy. (1992) (19)
- WITHDRAWN: Antivirals for the common cold. (2001) (19)
- Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction - a review of the regulatory evidence from the European Medicines Agency. (2017) (18)
- Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 2 - Hand hygiene and other hygiene measures: systematic review and meta-analysis. (2020) (17)
- Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy (2009) (17)
- Vaccines for preventing influenza in the elderly. (2006) (17)
- Vaccine safety--improving monitoring. (2001) (17)
- Vaccines for preventing influenza in healthy children. (2018) (16)
- An Economic Evaluation of the Introduction of Vaccination Against Hepatitis a in a Peacekeeping Operation: The Case of the United Nations Protection Force in Yugoslavia (1994) (16)
- Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports (2020) (16)
- Vaccines for preventing hepatitis B in health-care workers. (1997) (15)
- Reduction of Inappropriate Hospital Admissions of Children With Influenza-Like Illness Through the Implementation of Specific Guidelines: A Case-Controlled Study (2005) (15)
- Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration. (1998) (15)
- Relation between experimental and non-experimental study designs. HB vaccines: a case study. (1999) (14)
- Assessing quality of economic submissions to the BMJ (1995) (14)
- Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses (2008) (14)
- Vaccines for preventing influenza in healthy adults. (2004) (14)
- Background Paper on Influenza Vaccines and Immunization Background Paper on Influenza Vaccines and Immunization Sage Working Group Executive Summary Findings and Recommendations Background Paper on Influenza Vaccines and Immunization Background Paper on Influenza Vaccines and Immunization I. Context (14)
- Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review (2021) (14)
- A Hierarchical Framework for Assessing Transmission Causality of Respiratory Viruses (2021) (14)
- Economic aspects of vaccination. (1996) (13)
- Challenges of independent assessment of potential harms of HPV vaccines (2018) (13)
- Vaccines for preventing cholera. (2001) (13)
- H1N1 influenza and pandemic flu A special themed issue of the Health Technology Assessment journal series (2010) (12)
- Models of quality control for scientific research (2006) (12)
- What are the benefits of editorials and non-systematic reviews? (1999) (12)
- Influenza vaccination of health care workers (2013) (12)
- Influenza vaccination for elderly people and their care workers (2007) (11)
- Does oseltamivir really reduce complications of influenza? (2011) (11)
- Bioterrorism and compulsory vaccination (2004) (11)
- Sponsorship bias in clinical trials: growing menace or dawning realisation? (2020) (11)
- How to deal with influenza? (2004) (11)
- Ramifications of adverse events in children in Australia (2010) (11)
- SARS-CoV-2 and the role of fomite transmission: a systematic review (2021) (11)
- Influenza vaccines in adults. (2002) (10)
- Effectiveness of immune globulins in preventing infectious hepatitis and hepatitis A: a systematic review. (2004) (10)
- Redefining the ‘E’ in EBM (2018) (10)
- Why the MRC randomized trials of whooping cough (pertussis) vaccines remain important more than half a century after they were done (2007) (10)
- Hepatitis B vaccination: Risk‐benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation (2002) (10)
- Evidence-based vaccinology: the work of the Cochrane Vaccines Field. (1998) (10)
- Influenza vaccines in healthy children (2005) (10)
- Informed choice and balance are victims of the MMR-autism saga. (2004) (9)
- Do vaccines make best use of available resources? (in other words are they cost-effective?). (1999) (9)
- Neuropsychiatric adverse events and oseltamivir for prophylaxis. (2012) (9)
- Commentary on Cochrane review of neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. (2015) (9)
- Restoring biomedical literature with RIAT (2018) (9)
- Journals: how to decide what's worth publishing (2003) (8)
- SARS-CoV-2 and the role of orofecal transmission: a systematic review. (2021) (8)
- Assessing the Potential Cost Effectiveness of Pneumococcal Vaccines in the US (1999) (8)
- Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology (2020) (7)
- SARS-CoV-2 and the role of fomite transmission: a systematic review. (2021) (7)
- Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19 (2020) (7)
- Pneumococcal vaccines: confronting the confounders (2009) (7)
- SARS-CoV-2 and the role of close contact in transmission: a systematic review (2021) (7)
- Time for case-control studies of NSAIDs and oseltamivir (2009) (7)
- QALY league tables. (1994) (7)
- α +-Thalassemia and Protection from Malaria (2006) (7)
- [Influenza vaccination for healthcare workers who work with the elderly]. (2013) (7)
- WITHDRAWN: Vaccines for preventing anthrax. (2007) (7)
- An editorial policy statement: Submission of economic evaluations of vaccines (2002) (6)
- Amantadine and rimantadine for preventing and treating influenza A in adults. (2002) (6)
- Microbial challenge studies—a challenge worth accepting (2005) (6)
- Economic aspects of a small epidemic of hepatitis A in a religious community in Northern Italy. (1996) (6)
- Economic evaluations to aid decision to conduct a trial (1996) (5)
- Another question for GSK (2010) (5)
- A basic glossary of vaccinology (2001) (5)
- New and not so new vaccines (1996) (5)
- What is a ‘complex systematic review’? Criteria, definition, and examples (2018) (5)
- Economic Evaluation of Influenza Vaccination and Economic Modelling (2012) (5)
- Vaccines for preventing influenza in people with asthma. (2008) (5)
- More cases, doctor? Yes please! (2008) (5)
- Change from oral poliovirus vaccine to inactivated poliovirus vaccine (2002) (4)
- Vaccines for preventing cholera. (2000) (4)
- IMPLEMENTING A NATIONAL EARLY AWARENESS AND ALERT SYSTEM FOR NEW AND EMERGING HEALTH TECHNOLOGIES IN ITALY: THE COTE PROJECT (2012) (4)
- Oseltamivir for influenza (2016) (4)
- Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis (2012) (4)
- How to grab a headline: lots of smoke and little meat. (Response to Holmes et al.). (2006) (4)
- Time for change, WHO (2010) (4)
- Is the timing of recommended childhood vaccines evidence based? (2016) (4)
- Vaccines to prevent influenza in healthy adults (2013) (4)
- Evaluating the BMJ Guidelines for Economic Submissions (2013) (4)
- A systematic approach to medical decision-making of uncommon clinical pictures: A case of ulcerative skin lesions by palm tree thorn injury and a one-year follow-up (2005) (4)
- [Evidence-based emergency pathways for patients with acute coronary syndrome]. (2005) (4)
- Vaccines for preventing influenza in healthy adults. (2001) (4)
- Statins for primary prevention: what is the regulator’s role? (2020) (3)
- The neuraminidase inhibitors evidence of harms – in context (2016) (3)
- COLLABORATIVE MODELS FOR THE JOINT PRODUCTION OF CORE HEALTH TECHNOLOGY ASSESSMENTS: NEGATIVE AND POSITIVE ASPECTS FOR THE JOINT WORK OF DIFFERENT EUROPEAN AGENCIES (2014) (3)
- PCR Testing in the UK During the SARS-CoV-2 Pandemic - Evidence from FOI Requests (2022) (3)
- Effectiveness estimates in economic evaluation (2002) (3)
- SARS-CoV-2 and the role of fomite transmission: a systematic review [version 3; peer review: 2 approved] (2021) (3)
- Neuraminidase inhibitors for influenza complications (2014) (3)
- Placebo-the Unknown Variable in a Controlled Trial. (2021) (3)
- The Spanish influenza pandemic seen through the BMJ’s eyes: observations and unanswered questions (2009) (3)
- Viral cultures, PCR Cycle threshold values and viral load estimation for COVID-19 infectious potential assessment in transplant patients: systematic review - Protocol Version 29 December 2021 (2022) (3)
- Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications (2020) (3)
- Methodological quality of economic modelling studies. A case study with hepatitis B vaccines. (1998) (3)
- SARS-CoV-2 and the role of vertical transmission from infected pregnant women to their fetuses: systematic review. (2021) (3)
- Look at all the evidence before stockpiling amantadine (2007) (3)
- Peer review and publishing: it's time to move the agenda on Elisabeth Wager (2005) (3)
- Structuring the discussion of scientific papers (1999) (3)
- [Redefining the 'E' in EBM.] (2018) (3)
- The Impact of COVID-19 Restrictions on Childhood Vaccination Uptake: A Rapid Review (2021) (3)
- The role of editorial peer review in the evaluation of vaccine safety. (2004) (3)
- Vaccines and their real or perceived adverse effects (1999) (2)
- Disclose Data Publicly, without Restriction (2017) (2)
- Should journals sell reprints? No (2011) (2)
- Safety and efficacy of inactivated influenza vaccines in children. (2015) (2)
- An Emergency Clinical Pathway for Eclampsia and Pre-Eclampsia Patients in the Lazio Region (Italy) (2008) (2)
- Bufala spotting, part one: assessing research papers (2007) (2)
- The Spanish flu through the BMJ's eyes (2009) (2)
- The use of hepatitis A vaccine in Italy--evidence-based recommendations from an expert panel. (2003) (2)
- Neuraminidase Inhibitors and Influenza Infection. (2016) (2)
- Selective quotation of evidence in vaccines research (2004) (2)
- Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial (2020) (2)
- SARS-CoV-2 and the role of close contact in transmission: a systematic review. (2021) (2)
- Quality of impact factors of general medical journals - PRAVDA wins hands down (2017) (2)
- Economic burden of communicable disease outbreak in a military unit. (1994) (2)
- Methodological quality of economic evaluations of health care interventions (2002) (2)
- Vaccines for preventing influenza in healthy adults. (2007) (2)
- Wireless capsule endoscopy in Italy: Adding context-specific data to the review of the evidence from literature (2009) (2)
- Implantable devices for the closure of patent foramen ovale in adults: an Italian rapid health technology assessment (2014) (2)
- Increased incidence of cervical cancer in Sweden: an unlikely link with human papillomavirus (HPV) vaccination (2019) (2)
- 1st International Symposium on the Evaluation of Safety of Human Vaccines (2002) (2)
- Are the Results of Hospital Based Studies Generalisable to the Pre-Hospital Setting? (2004) (2)
- Influenza vaccines in healthy children [3] (multiple letters) (2005) (1)
- [Facing the unreliability of clinical trials literature]. (2016) (1)
- Resource reviews (2004) (1)
- Viral Cultures for Assessing Airborne Transmission of SARS-CoV-2: a Systematic Review Protocol (2022) (1)
- SARS-CoV-2 and the role of close contact in transmission: a systematic review. (2021) (1)
- Transmission of SARS-CoV-2 associated with cruise ship travel: protocol for a systematic review (Version 1) (2021) (1)
- Physical interventions to interrupt or reduce the spread of respiratory viruses (2023) (1)
- Methodological Quality of Economic Modelling Studies (1998) (1)
- Sars-Cov-2 exposures of healthcare workers and acquisition of COVID-19 (2022) (1)
- Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence (2020) (1)
- The First International Symposium on Vaccine Safety (2004) (1)
- Oseltamivir for influenza (2015) (1)
- Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review (Version 1) (2021) (1)
- Hadrontherapy for cancer. An overview of HTA reports and ongoing studies (2019) (1)
- Neuraminidase inhibitors produce a small reduction in duration of seasonal influenza in children and reduce transmission in affected households, but effects on serious complications unclear (2010) (1)
- Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals. A systematic review (2021) (1)
- Clinical trials: Tamiflu reviewers respond to critics (2014) (1)
- Streptococcus pneumoniae incidence in western Europe – Authors' reply (2007) (1)
- Antivirals for influenza in healthy adults – Authors' reply (2006) (1)
- Detecting plagiarism: Current quality control systems don't work (2006) (1)
- Ranking antidepressants (2009) (1)
- Systematic review of economic evaluation on the use of PET-CT for cancer staging. (2011) (1)
- How to deal with influenza: Author's reply (2004) (1)
- SARS-CoV-2 and the role of fomite transmission: a systematic review [version 1; peer review: 2 approved with reservations] (2021) (1)
- [Multisystem failure: the story of antinfluenza drugs]. (2014) (1)
- Why COVID-19 modelling of progression and prevention fails to translate to the real-world (2022) (1)
- SARS-CoV-2 and the role of fomite transmission: a systematic review [version 1; peer review: 1 approved with reservations] (2021) (1)
- Attenti alle bufale ("beware of red herrings"), or, how to make evidence-based medicine work for you. (2006) (1)
- Does a pre-hospital emergency pathway improve early diagnosis and referral in suspect stroke patients? Protocol for cluster randomised trial. (2005) (1)
- Cochrane Reviews and Systematic Reviews of Economic Evaluations (2012) (1)
- The evidence on transmission dynamics of COVID-19 from pre and asymptomatic cases: protocol for a systematic review (2021) (1)
- A Literature Review of the Cost-Effectiveness of Nuclear Medicine (1995) (1)
- Economic Analysis of Influenza Vaccination and Treatment (2003) (1)
- Antivirals for Treatment of Influenza (2012) (0)
- Control vaccine formulation (2021) (0)
- Informed choice, balance, and the MMR–autism saga–Authors' reply (2005) (0)
- Reasons for exclusion of studies based on full manuscripts (2016) (0)
- Tamiflu (oseltamivir) clinical study reports (2014) (0)
- Coinfection with Strongyloides and SARS-CoV-2: A Systematic Review (2023) (0)
- Bufale Spotting, part 9: assessing an economic evaluation (2008) (0)
- Bioterrorism and compulsory vaccination: Author's reply (2004) (0)
- BMJ pico—a window into the future? (2009) (0)
- Stage 1 of the 2012 A159 review (2016) (0)
- Interventions designed to improve vaccination uptake: Scoping review of systematic reviews and meta-analyses - protocol (version 1) (2021) (0)
- Amantadine and rimantadine for preventing and treating influenza A in adults. (2000) (0)
- The Politics of Emerging and Resurgent Infectious Diseases edited by Jim Whitman. Macmillan Press, Basingstoke, 2000. No. of pages 223. ISBN 0-333-69127-X (2001) (0)
- Vaccines for preventing hepatitis B in health care workers. (2001) (0)
- Bufale Spotting, part 10: assessing a journal (2008) (0)
- Step by step: an inter-disciplinary project to improve quality in writing peer reviewed scientific articles (2009) (0)
- Bufale Spotting, part 6: Assessing a lecture (2007) (0)
- Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review update (2022) (0)
- Modified Consolidated Standards of Reporting Trials statement-based extraction template for clinical study reports (2016) (0)
- Compliharms: events alternatively recorded as complications or harms (2016) (0)
- Letter to the Editor. Re: Rufino de Sousa et al., 2022. Detection and isolation of airborne SARS‐CoV‐2 in a hospital setting. Indoor Air, 32 (3), e13023 (2022) (0)
- Open letter to Gro Harlem Bruntland on her accession to the Directorate General of the World Health Organization. (1998) (0)
- Aluminium-containing DTP vaccines — Authors' Reply (2004) (0)
- Bufale Spotting, part 4: Assessing a guideline (2007) (0)
- RIAT: HPV AAHS control rationale (2018) (0)
- Observational Data on Harm is Already Included in Systematic Reviews (2017) (0)
- VP101 Medical Devices For Treatment-resistant Hypertension: Health Technology Assessment Report (2017) (0)
- Re:Adverse events following influenza vaccination in Australia--should we be surprised? (2020) (0)
- Bufale spotting, part three: assessing editorials (2007) (0)
- Post-protocol hypotheses: methods and results (2016) (0)
- Searches of the electronic databases (2016) (0)
- Bufale Spotting, part 5: Assessing a website (2007) (0)
- Assessing Muscle-Related Adverse Events in Randomized Trials of Statins (2022) (0)
- Bufale spotting, part 8: assessing a letter to a journal. (2007) (0)
- Example of contents of a Clinical Study Report (from p. 1 of WV15670 report) (2016) (0)
- Contradictory findings on efficacy of neuraminidase inhibitors not cited. (2020) (0)
- drug and therapeutics bulletin of navarre , spain Facing the unreliability of clinical trials literature (2015) (0)
- The story of A159 (2016) (0)
- Capsule endoscopy in Italy: An unbalanced review of the literature. Authors' response (2010) (0)
- WHO – Time for a Change (2017) (0)
- Influenza like Illness (ILI): prescribing behaviour of 83 sentry doctors in Lazio region in the period 2001-2002. Is it adherent to Italian ILI guidelines? (2007) (0)
- Refining the E in EBM (2020) (0)
- [Plagiarism. A fools' errand.] (2017) (0)
- More clarifications needed from GSK (2017) (0)
- Author's response to influenza vaccination: policy v evidence (2006) (0)
- Bufale spotting, part two: assessing systematic reviews. (2007) (0)
- Horizon Scanning report N ° 3 Minimally invasive treatment for atrial fibrillatio n by high intensity ultrasound ( HIFU ) ablation July 2009 (2009) (0)
- 3631 POSTER Health Technology Assessment of High-intensity Focused Ultrasounds for Prostate Cancer (2011) (0)
- PICO - a window into the future? (2017) (0)
- Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence (2020) (0)
- Applying inclusion criteria for the A159 2012 review (2016) (0)
- A withdrawn prepublication (2007) (0)
- Do cholera vaccines prevent cholera? Evidence Update, Other Infectious Diseases Series, February 2005 (2005) (0)
- Viral cultures, Polymerase Chain Reaction Cycle Threshold Values and Viral Load Estimation for SARS-CoV-2 Infectious Potential Assessment in Hematopoietic Stem Cell and Solid Organ Transplant Patients: A Systematic Review (2022) (0)
- Jefferson a century after they were done Why the MRC randomized trials of whooping cough ( pertussis ) vaccines remain important more than half (2007) (0)
- Interventions designed to improve vaccination uptake: Scoping review of systematic reviews and meta-analyses - (version 1) (2022) (0)
- International Symposium on Vaccine Safety (2004) (0)
- Get Peered! (2003) (0)
- The Role of Health Technology Assessment in Vitro Device Development: The Example of Rapid (Bed-Side) Tests for Influenza Assessment (2009) (0)
- SARS-CoV-2 and the role of fomite transmission : a systematic review [ version 2 ; peer review : 2 approved ] (2021) (0)
- Stephen Lock provides examples of the rejection of papers by two Shortcomings of peer review in biomedical journals (0)
- Advances in the diagnosis and management of influenza (2002) (0)
- OP79 Experimenting HTAi Patient Group Submission Template To Involve Patients (2017) (0)
- Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update (2022) (0)
- Neuraminidase inhibitors for influenza in healthy adults : What we don ’ t know (2010) (0)
- Template of letter sent to corresponding authors of included studies (2016) (0)
- Illustration of time-dependent bias using individual patient data from the Canadian study (2016) (0)
- Cochrane and the new McCarthyism. (2019) (0)
- Attenti Alle Bufale (‘Beware of Red Herrings’), or, How to Make Evidence-Based Medicine Work for You (2006) (0)
- Viral Cultures for Assessing Fomites Transmission of SARS-CoV-2: a Systematic Review Protocol (2022) (0)
- Authors’ reply to Dunning (2014) (0)
- The Measures of Medicine: Benefits, Harms, and Costs (1995) (0)
- A brief history of shroud waving through the centuries (2009) (0)
- Symptomatic influenza-like illness in prophylaxis trials (2016) (0)
- Searches for regulatory information (2016) (0)
- Oral oseltamivir is an effective treatment of acute influenza in adults (2000) (0)
- Accommodating intraocular lenses for patients with cataract: a review (2011) (0)
- An open letter to the NSABB re the political and ethical implications of lethal virus development (2012) (0)
- Effect of oseltamivir on mortality in patients with 2009A/H1N1 influenza: a systematic review and individual patient data meta-analysis of observational studies (2016) (0)
- Transmission of SARS-CoV-2 Associated with Cruise Ship Travel: A Systematic Review (2022) (0)
- Validation of clinical guideline content using Cochrane reviews: the case of WHO's Adult Lung Health Initiative (ALHI) (2001) (0)
- Darkness falls (2008) (0)
- Bufale Spotting, part 7: Assessing an advert (2007) (0)
- The evidence base for new drugs (2015) (0)
- Oseltamivir observational studies review search strategies (2016) (0)
- Resource reviews (2009) (0)
- Bufale Spotting, part 8: Assessing a letter to a journal (2007) (0)
- Bufale spotting, part two: assessing systematic reviews (2007) (0)
- Sticking to principles and anticipating outcomes (2017) (0)
- 10 The European Registration of the Pandemic Influenza Vaccine Pandemrix: A Case Study of the Consequences of Poor Clinical Data Transparency (2021) (0)
This paper list is powered by the following services:
Other Resources About Tom Jefferson
What Schools Are Affiliated With Tom Jefferson ?
Tom Jefferson is affiliated with the following schools:
